Idiopathic eosinophilia [2] (multiple letters)

[1]  R. Dummer,et al.  Correction: Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic Eosinophilia. , 1999, The New England journal of medicine.

[2]  B. Bain.  Eosinophilia--idiopathic or not? , 1999, The New England journal of medicine.

[3]  S. Whittaker,et al.  T-cell receptor gene analysis in the diagnosis of Se ́zary syndrome , 1999 .

[4]  P. Marrack,et al.  Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.

[5]  R. Dummer,et al.  A Rational Approach to the Therapy of Cutaneous T–Cell Lymphomas , 1996 .

[6]  G. Wood,et al.  No detection of HTLV‐I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T‐cell lymphoma , 1996, The British journal of dermatology.

[7]  M. Goldman,et al.  Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. , 1996, The Journal of clinical investigation.

[8]  M. Goldman,et al.  Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. , 1994, The New England journal of medicine.

[9]  S. Steinberg,et al.  Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome , 1993, Cancer.

[10]  M. Tomonaga,et al.  Frequency of eosinophilia in adult T‐cell leukemia/lymphoma , 1992, Cancer.

[11]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[12]  B. Farber,et al.  Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. , 1991, The American journal of medicine.

[13]  T. Honjo,et al.  Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related , 1989, The Journal of experimental medicine.